Boehringer Ingelheim GmbH, of Ingelheim, Germany, said the Jordan Food and Drug Administration approved Pradaxa (dabigatran etexilate) for the prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation, marking the 100th approval of the thrombin inhibitor.

Endo International plc, of Dublin, said it received FDA approval of Aveed (testosterone undecanoate) injection for the treatment of adult men with hypogonadism that is associated with a deficiency or absence of male hormone testosterone.